ArticleMedicine2026
Traditional Chinese medicine treatment in a patient with severe COVID-19: A case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
rationaleElderly patients with severe COVID-19 frequently develop chronic critical illness marked by prolonged ventilation, multidrug-resistant infections, enteral-nutrition (EN) intolerance, and persistent inflammation-immunosuppression-catabolism syndrome, making liberation from the ventilator and recovery difficult. Integrative Chinese and Western medicine (ICWM) is hypothesized to modulate immunity and the gut-lung axis and to stabilize frail physiology during long ICU courses. PATIENT CONCERNS: An 87-year-old man with >10-year Parkinson's disease experienced septic shock, invasive ventilation, and tracheotomy after COVID-19, prompting a request for ICWM. DIAGNOSES: Severe pneumonia due to COVID-19 (CURB-65 score of 3); multiple organ dysfunction syndrome (respiratory failure, acute renal failure, and acute heart failure); sepsis; malnutrition; Parkinson's disease; and lower extremity venous thrombosis. The traditional Chinese medicine diagnosis was based on "epidemic disease," with dampness toxin stagnation in the lung, and spleen and kidney deficiency.
interventionsA multidisciplinary team delivered individualized ICWM aligned with the "Shanghai Expert Consensus" and the traditional Chinese medicine principle of "benefiting qi and strengthening the body." Prescriptions were dynamically adjusted to syndrome evolution and to gastrointestinal tolerance, successively including Buzhong Yiqi decoction, Shenling Baizhu powder, Weijing decoction, Tounong decoction, and Shengxian decoction; when gastrointestinal absorption was limited or shock was present, intravenous Shenfu injection was added. Standard care comprised culture-guided antimicrobials, bronchoscopy-assisted secretion clearance, invasive ventilatory support, and nutrition therapy with EN. The ICWM plan was titrated specifically to address EN-intolerance diarrhea and to support nutritional rehabilitation. OUTCOMES: After treatment, intolerance symptoms improved; sputum cultures converted to negative by ICU day 41. The patient weaned from mechanical ventilation and the tracheal tube 10 days later, and remained afebrile without productive cough, enabling discharge to home convalescence. LESSONS: This case highlights the need for ICWM in critically ill patients, especially in those with chronic critical illness and persistent inflammation-immunosuppression-catabolism syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.